Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Vincent CC Cheng, Sally CY Wong, Pak-Leung Ho & Kwok-Yung Yuen. (2015) Strategic measures for the control of surging antimicrobial resistance in Hong Kong and mainland of China. Emerging Microbes & Infections 4:1, pages 1-13.
Read now
Read now
Yen-Hsu Chen, Wen-Chien Ko & Po-Ren Hsueh. (2013) Emerging resistance problems and future perspectives in pharmacotherapy for complicated urinary tract infections. Expert Opinion on Pharmacotherapy 14:5, pages 587-596.
Read now
Read now
Catherine S. O'Neal, Hollis R. O'Neal, Titus L. Daniels & Thomas R. Talbot. (2012) Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia. Scandinavian Journal of Infectious Diseases 44:10, pages 726-732.
Read now
Read now
Jesús Rodríguez-Baño & Alvaro Pascual. (2008) Clinical significance of extended-spectrum β-lactamases. Expert Review of Anti-infective Therapy 6:5, pages 671-683.
Read now
Read now
Axel Kola, Oliver Maciejewski, Dorit Sohr, Stefan Ziesing & Petra Gastmeier. (2007) Clinical impact of infections caused by ESBL-producing E. coli and K. pneumoniae. Scandinavian Journal of Infectious Diseases 39:11-12, pages 975-982.
Read now
Read now
Articles from other publishers (73)
H. Namikawa, W. Imoto, K. Yamada, Y. Tochino, Y. Kaneko, H. Kakeya & T. Shuto. (2023) Predictors for onset of extended-spectrum beta-lactamase-producing Escherichia coli-induced bacteraemia: a systematic review and meta-analysis. Journal of Hospital Infection 142, pages 88-95.
Crossref
Crossref
Kathryn L McDonald, Sarah Garland, Carolee A Carson, Kimberly Gibbens, E Jane Parmley, Rita Finley & Melissa C MacKinnon. (2021)
Measures used to assess the burden of ESBL-producing
Escherichia coli
infections in humans: a scoping review
. JAC-Antimicrobial Resistance 3:1.
Crossref
Crossref
M. C. MacKinnon, J. M. Sargeant, D. L. Pearl, R. J. Reid-Smith, C. A. Carson, E. J. Parmley & S. A. McEwen. (2020) Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis. Antimicrobial Resistance & Infection Control 9:1.
Crossref
Crossref
David L. Paterson, Andrew Henderson & Patrick N.A. Harris. (2020) Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia. Current Opinion in Infectious Diseases 33:1, pages 78-85.
Crossref
Crossref
Evelina Tacconelli, Maria Adriana Cataldo, Nico T. Mutters, Elena Carrara, Alessandro Bartoloni, Annibale Raglio, Roberto Cauda, Elisabetta Mantengoli, Francesco Luzzaro, Angelo Pan, Lia A. Beccara, Patrizia Pecile, Marco Tinelli & Gian Maria Rossolini. (2019) Role of place of acquisition and inappropriate empirical antibiotic therapy on the outcome of extended-spectrum β-lactamase-producing Enterobacteriaceae infections. International Journal of Antimicrobial Agents 54:1, pages 49-54.
Crossref
Crossref
Soo Kyung Son, Na Rae Lee, Jae-Hoon Ko, Jae Ki Choi, Soo-Youn Moon, Eun Jeong Joo, Kyong Ran Peck & Dong Ah Park. (2018) Clinical effectiveness of carbapenems versus alternative antibiotics for treating ESBL-producing Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy 73:10, pages 2631-2642.
Crossref
Crossref
Peter M Hawkey, Roderic E Warren, David M Livermore, Cliodna A M McNulty, David A Enoch, Jonathan A Otter & A Peter R Wilson. (2018) Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†. Journal of Antimicrobial Chemotherapy 73:suppl_3, pages iii2-iii78.
Crossref
Crossref
Amine Cheikh, Bouchra Belefquih, Younes Chajai, Younes Cheikhaoui, Amine El Hassani & Amina Benouda. (2017) Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) colonization as a risk factor for developing ESBL infections in pediatric cardiac surgery patients: “retrospective cohort study”. BMC Infectious Diseases 17:1.
Crossref
Crossref
J. Martín Jaramago, R. Armero Ibáñez, J.J. Camarena Miñana & M. Morales Suárez-Varela. (2017) Resistance profiles and risk factors of resistant microorganisms in bacteraemia of abdominal origin. Revista Española de Anestesiología y Reanimación (English Edition) 64:9, pages 490-498.
Crossref
Crossref
J. Martín Jaramago, R. Armero Ibáñez, J.J. Camarena Miñana & M. Morales Suárez-Varela. (2017) Perfiles de resistencia y factores de riesgo de microorganismos resistentes en bacteriemia de origen abdominal. Revista Española de Anestesiología y Reanimación 64:9, pages 490-498.
Crossref
Crossref
Hosam M. Zowawi, Patrick N. A. Harris, Matthew J. Roberts, Paul A. Tambyah, Mark A. Schembri, M. Diletta Pezzani, Deborah A. Williamson & David L. Paterson. (2015) The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nature Reviews Urology 12:10, pages 570-584.
Crossref
Crossref
João M. Costa Ramos, Claudia Stein, Yvonne Pfeifer, Christian Brandt, Mathias W. Pletz & Oliwia Makarewicz. (2015) Mutagenesis of the CTX-M-type ESBL—is MIC-guided treatment according to the new EUCAST recommendations a safe approach?. Journal of Antimicrobial Chemotherapy 70:9, pages 2528-2535.
Crossref
Crossref
Giorgia Valsesia, Malgorzata Roos, Erik C. Böttger & Michael Hombach. (2015) A Statistical Approach for Determination of Disk Diffusion-Based Cutoff Values for Systematic Characterization of Wild-Type and Non-Wild-Type Bacterial Populations in Antimicrobial Susceptibility Testing. Journal of Clinical Microbiology 53:6, pages 1812-1822.
Crossref
Crossref
Giorgia Valsesia, Michael Hombach, Florian P. Maurer, Patrice Courvalin, Malgorzata Roos & Erik C. Böttger. (2015) The Resistant-Population Cutoff (RCOFF): a New Concept for Improved Characterization of Antimicrobial Susceptibility Patterns of Non-Wild-Type Bacterial Populations. Journal of Clinical Microbiology 53:6, pages 1806-1811.
Crossref
Crossref
B. Clouzeau, A. Boyer, F. M’Zali, M. Kann & D. Gruson. (2015) Nouvelles stratégies thérapeutiques contre les entérobactéries productrices de β-lactamases à spectre étenduNew treatment strategies for extended-spectrum β-lactamase-producing enterobacteriaceae. Réanimation 24:3, pages 270-277.
Crossref
Crossref
Florian P. Maurer, Patrice Courvalin, Erik C. Böttger & Michael Hombach. (2014) Integrating Forecast Probabilities in Antibiograms: a Way To Guide Antimicrobial Prescriptions More Reliably?. Journal of Clinical Microbiology 52:10, pages 3674-3684.
Crossref
Crossref
Kim W. Benner, Priya Prabhakaran & Autumn S. Lowros. (2014) Epidemiology of Infections Due to Extended-Spectrum Beta-Lactamase–Producing Bacteria in a Pediatric Intensive Care Unit. The Journal of Pediatric Pharmacology and Therapeutics 19:2, pages 83-90.
Crossref
Crossref
Cheol-In Kang, Min Kyeong Cha, So Hyun Kim, Yu Mi Wi, Doo Ryeon Chung, Kyong Ran Peck, Nam Yong Lee & Jae-Hoon Song. (2014) Extended-spectrum cephalosporins and the inoculum effect in tests with CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli: Potential clinical implications of the revised CLSI interpretive criteria. International Journal of Antimicrobial Agents 43:5, pages 456-459.
Crossref
Crossref
Yoon Soo ParkIl Kwon BaeJuwon KimSeok Hoon JeongSeung-sik HwangYiel-Hea SeoYong Kyun ChoKyungwon LeeJune Myung Kim. (2014)
Risk Factors and Molecular Epidemiology of Community-Onset Extended-Spectrum β-Lactamase-Producing
Escherichia coli
Bacteremia
. Yonsei Medical Journal 55:2, pages 467.
Crossref
Crossref
Christopher BoganDror Marchaim. (2013) The role of antimicrobial stewardship in curbing carbapenem resistance. Future Microbiology 8:8, pages 979-991.
Crossref
Crossref
Jonathan H. K. Chen, Pak-Leung Ho, Grace S. W. Kwan, Kevin K. K. She, Gilman K. H. Siu, Vincent C. C. Cheng, Kwok-Yung Yuen & Wing-Cheong Yam. (2013) Direct Bacterial Identification in Positive Blood Cultures by Use of Two Commercial Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry Systems. Journal of Clinical Microbiology 51:6, pages 1733-1739.
Crossref
Crossref
Kelvin K.W. To, Wai-U Lo, Jasper F.W. Chan, Herman Tse, Vincent C.C. Cheng & Pak-Leung Ho. (2013) Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity. International Journal of Infectious Diseases 17:2, pages e120-e124.
Crossref
Crossref
Yeon-Joon ParkWonkeun Song. (2013)
Strategies for Interpretive Standards of β-Lactams Susceptibility Testing and Identification of Extended-Spectrum β-Lactamases and Carbapenemases in
Enterobacteriaceae
. Annals of Clinical Microbiology 16:3, pages 111.
Crossref
Crossref
Daisik KoSong Mi MoonJi Sung LeeYoon Soo ParkYong Kyun Cho. (2013)
Risk Factors of Nosocomial Bacteremia of Extended-spectrum β-Lactamase Producing
Escherichia coli
. Yeungnam University Journal of Medicine 30:2, pages 83.
Crossref
Crossref
A. Gündoğdu, Y. B. Long & M. Katouli. (2012) Prevalence and pathogenesis of extended-spectrum beta-lactamase producing Escherichia coli causing urinary tract infection in hospitalized patients. European Journal of Clinical Microbiology & Infectious Diseases 31:11, pages 3107-3116.
Crossref
Crossref
Enrico Maria Trecarichi, Roberto Cauda & Mario Tumbarello. (2012)
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing
Enterobacteriaceae
bloodstream infections
. Future Microbiology 7:10, pages 1173-1189.
Crossref
Crossref
Mark Melzer & Irene Petersen. (2012) A re-audit of outcomes in patients with ESBL producing Escherichia coli bacteraemia. Journal of Infection 65:3, pages 283-284.
Crossref
Crossref
Hae Suk CheongKwan Soo KoCheol-In KangDoo Ryeon ChungKyong Ran PeckJae-Hoon Song. (2012)
Clinical Significance of Infections Caused by Extended-Spectrum β-Lactamase-Producing
Enterobacteriaceae
Blood Isolates with Inducible AmpC β-Lactamase
. Microbial Drug Resistance 18:4, pages 446-452.
Crossref
Crossref
D. M. Livermore, J. M. Andrews, P. M. Hawkey, P.-L. Ho, Y. Keness, Y. Doi, D. Paterson & N. Woodford. (2012) Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?. Journal of Antimicrobial Chemotherapy 67:7, pages 1569-1577.
Crossref
Crossref
Wouter C. Rottier, Heidi S. M. Ammerlaan & Marc J. M. Bonten. (2012) Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. Journal of Antimicrobial Chemotherapy 67:6, pages 1311-1320.
Crossref
Crossref
Pak Leung Ho, Man Kiu Yeung, Wai U Lo, Herman Tse, Zhen Li, Eileen L. Lai, Kin Hung Chow, Kelvin K. To & Wing Cheong Yam. (2012) Predominance of pHK01-like incompatibility group FII plasmids encoding CTX-M-14 among extended-spectrum beta-lactamase–producing Escherichia coli in Hong Kong, 1996–2008. Diagnostic Microbiology and Infectious Disease 73:2, pages 182-186.
Crossref
Crossref
A. Lefort & M.-H. Nicolas-Chanoine. (2012) Les entérobactéries productrices de β-lactamases à spectre étendu (BLSE) et les céphalosporines de troisième génération en 2012. Journal des Anti-infectieux 14:2, pages 51-57.
Crossref
Crossref
Vicki L. Collins, Dror Marchaim, Jason M. Pogue, Judy Moshos, Suchitha Bheemreddy, Bharath Sunkara, Alex Shallal, Neelu Chugh, Sara Eiseler, Pragati Bhargava, Christopher Blunden, Paul R. Lephart, Babar Irfan Memon, Kayoko Hayakawa, Odaliz Abreu-Lanfranco, Teena Chopra, L. Silvia Munoz-Price, Yehuda Carmeli & Keith S. Kaye. (2012) Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 56:4, pages 2173-2177.
Crossref
Crossref
. (2012) Antibiotics - (Vol. 16, No. 2, Full Issue). Asia-Pacific Biotech News 16:02.
Crossref
Crossref
. (2012) FEATURES. Asia-Pacific Biotech News 16:02, pages 15-33.
Crossref
Crossref
Didier Schoevaerdts, Pierre Bogaerts, Alexandre Grimmelprez, Marie de Saint-Hubert, Bénédicte Delaere, Jacques Jamart, Christian Swine & Youri Glupczynski. (2011) Clinical profiles of patients colonized or infected with extended-spectrum beta-lactamase producing Enterobacteriaceae isolates: a 20 month retrospective study at a Belgian University Hospital. BMC Infectious Diseases 11:1.
Crossref
Crossref
Florian M.E. Wagenlehner, Adrian Pilatz & Wolfgang Weidner. (2011) Urosepsis—from the view of the urologist. International Journal of Antimicrobial Agents 38, pages 51-57.
Crossref
Crossref
M. Ortega, F. Marco, A. Soriano, M. Almela, J. A. Martínez, J. López, C. Pitart & J. Mensa. (2011) Cefotaxime resistance and outcome of Klebsiella spp bloodstream infection. European Journal of Clinical Microbiology & Infectious Diseases 30:12, pages 1599-1605.
Crossref
Crossref
Shin-ichi Fujita, Kentaro Yosizaki, Thikako Ogushi, Kouhei Uechi, Yukiko Takemori & Yasuko Senda. (2011) Rapid Identification of Gram-Negative Bacteria with and without CTX-M Extended-Spectrum β-Lactamase from Positive Blood Culture Bottles by PCR Followed by Microchip Gel Electrophoresis. Journal of Clinical Microbiology 49:4, pages 1483-1488.
Crossref
Crossref
E. Cercenado. (2011) Impacto pronóstico de las betalactamasas de espectro extendido. Revista Clínica Española 211:3, pages 139-141.
Crossref
Crossref
Pak-Leung Ho, Kin-Hung Chow, Wai-U. Lo, Kelvin K. To & Vincent C. Cheng. (2011) Effect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong Kong. International Journal of Antimicrobial Agents 37:3, pages 270-271.
Crossref
Crossref
Dror Marchaim, Tamar Gottesman, Orna Schwartz, Maya Korem, Yasmin Maor, Galia Rahav, Rebekah Karplus, Tsipora Lazarovitch, Eyal Braun, Hana Sprecher, Tamar Lachish, Yonit Wiener-Well, Danny Alon, Michal Chowers, Pnina Ciobotaro, Rita Bardenstein, Alona Paz, Israel Potasman, Michael Giladi, Vered Schechner, Mitchell J. Schwaber, Shiri Klarfeld-Lidji & Yehuda Carmeli. (2010)
National Multicenter Study of Predictors and Outcomes of Bacteremia upon Hospital Admission Caused by
Enterobacteriaceae
Producing Extended-Spectrum β-Lactamases
. Antimicrobial Agents and Chemotherapy 54:12, pages 5099-5104.
Crossref
Crossref
Michael PfallerAndrea Endimiani. 2010. Kucers' The Use of Antibiotics Sixth Edition. Kucers' The Use of Antibiotics Sixth Edition
405
421
.
Un-In Wu, Ching-Shiang Yang, Wan-Chin Chen, Yee-Chun Chen & Shan-Chwen Chang. (2010) Risk Factors for Bloodstream Infections due to Extended-spectrum β-lactamase-producing Escherichia coli. Journal of Microbiology, Immunology and Infection 43:4, pages 310-316.
Crossref
Crossref
F.M.E. Wagenlehner, C. Lichtenstern, M.A. Weigand & W. Weidner. (2010) Urosepsis und TherapieUrosepsis and treatment. Der Urologe 49:5, pages 618-622.
Crossref
Crossref
P.L. Ho, A.Y. Ho, K.H. Chow, E.L. Lai, P. Ching & W.H. Seto. (2010) Epidemiology and clonality of multidrug-resistant Acinetobacter baumannii from a healthcare region in Hong Kong. Journal of Hospital Infection 74:4, pages 358-364.
Crossref
Crossref
C. Gudiol, L. Calatayud, C. Garcia-Vidal, J. Lora-Tamayo, M. Cisnal, R. Duarte, M. Arnan, M. Marin, J. Carratala & F. Gudiol. (2009) Bacteraemia due to extended-spectrum -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome. Journal of Antimicrobial Chemotherapy 65:2, pages 333-341.
Crossref
Crossref
J. Hsu, D. R. Andes, V. Knasinski, J. Pirsch & N. Safdar. (2009) Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients. European Journal of Clinical Microbiology & Infectious Diseases 28:11, pages 1343-1351.
Crossref
Crossref
M. Ortega, F. Marco, A. Soriano, M. Almela, J. A. Martínez, A. Muñoz & J. Mensa. (2009) Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. Journal of Antimicrobial Chemotherapy 63:3, pages 568-574.
Crossref
Crossref
S.-S. Jean, P.-R. Hsueh, W.-S. Lee, H.-T. Chang, M.-Y. Chou, I.-S. Chen, J.-H. Wang, C.-F. Lin, J.-M. Shyr, W.-C. Ko, J.-J. Wu, Y.-C. Liu, W.-K. Huang, L.-J. Teng & C.-Y. Liu. (2008) Nationwide surveillance of antimicrobial resistance among Enterobacteriaceae in intensive care units in Taiwan. European Journal of Clinical Microbiology & Infectious Diseases 28:2, pages 215-220.
Crossref
Crossref
Silvia Figueiredo Costa. (2008) IMPACT OF ANTIMICROBIAL RESISTANCE ON THE TREATMENT AND OUTCOME OF PATIENTS WITH SEPSIS. Shock 30:7, pages 23-29.
Crossref
Crossref
C. O. Akujobi, J. N. Ogbulie & C. S. Alisi. (2008) Occurrence of extended-spectrum β-lactamases in Escherichia coli isolated from piggery farms in Imo State, Nigeria. World Journal of Microbiology and Biotechnology 24:10, pages 2167-2170.
Crossref
Crossref
Johann DD Pitout & Kevin B Laupland. (2008) Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. The Lancet Infectious Diseases 8:3, pages 159-166.
Crossref
Crossref
C. Peña, C. Gudiol, L. Calatayud, F. Tubau, M.A. Domínguez, M. Pujol, J. Ariza & F. Gudiol. (2008) Infections due to Escherichia coli producing extended-spectrum β-lactamase among hospitalised patients: factors influencing mortality. Journal of Hospital Infection 68:2, pages 116-122.
Crossref
Crossref
J. Rodríguez-Baño & M.D. Navarro. (2008) Extended-spectrum β-lactamases in ambulatory care: a clinical perspective. Clinical Microbiology and Infection 14, pages 104-110.
Crossref
Crossref
P. Reddy, M. Malczynski, A. Obias, S. Reiner, N. Jin, J. Huang, G. A. Noskin & T. Zembower. (2007) Screening for Extended-Spectrum -Lactamase-Producing Enterobacteriaceae among High-Risk Patients and Rates of Subsequent Bacteremia. Clinical Infectious Diseases 45:7, pages 846-852.
Crossref
Crossref
Mark Melzer & Irene Petersen. (2007) Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. Journal of Infection 55:3, pages 254-259.
Crossref
Crossref
Emily P. Hyle, Warren B. Bilker, Leanne B. Gasink & Ebbing Lautenbach. (2015) Impact of Different Methods for Describing the Extent of Prior Antibiotic Exposure on the Association Between Antibiotic Use and Antibiotic-Resistant Infection. Infection Control & Hospital Epidemiology 28:6, pages 647-654.
Crossref
Crossref
Miles Denton. (2007) Enterobacteriaceae. International Journal of Antimicrobial Agents 29, pages S9-S22.
Crossref
Crossref
J. Rodriguez-Bano, M. D. Navarro, L. Romero, M. A. Muniain, M. d. Cueto, M. J. Rios, J. R. Hernandez & A. Pascual. (2006) Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge. Clinical Infectious Diseases 43:11, pages 1407-1414.
Crossref
Crossref
Cao Bin, Wang Hui, Zhu Renyuan, Ning Yongzhong, Xie Xiuli, Xu Yingchun, Zhu Yuanjue & Chen Minjun. (2006) Outcome of cephalosporin treatment of bacteremia due to CTX-M–type extended-spectrum β-lactamase–producing Escherichia coli. Diagnostic Microbiology and Infectious Disease 56:4, pages 351-357.
Crossref
Crossref
I. Skippen, M. Shemko, J. Turton, M.E. Kaufmann, C. Palmer & N. Shetty. (2006) Epidemiology of infections caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp.: a nested case–control study from a tertiary hospital in London. Journal of Hospital Infection 64:2, pages 115-123.
Crossref
Crossref
Reuben Ramphal & Paul G. Ambrose >. (2006) Extended-Spectrum β-Lactamases and Clinical Outcomes: Current Data. Clinical Infectious Diseases 42:Supplement_4, pages S164-S172.
Crossref
Crossref
Mitchell J. Schwaber, Shiri Navon-Venezia, Keith S. Kaye, Ronen Ben-Ami, David Schwartz & Yehuda Carmeli. (2006)
Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing
Enterobacteriaceae
. Antimicrobial Agents and Chemotherapy 50:4, pages 1257-1262.
Crossref
Crossref
R. Ben-Ami, M. J. Schwaber, S. Navon-Venezia, D. Schwartz, M. Giladi, I. Chmelnitsky, A. Leavitt & Y. Carmeli. (2006) Influx of Extended-Spectrum -Lactamase--Producing Enterobacteriaceae into the Hospital. Clinical Infectious Diseases 42:7, pages 925-934.
Crossref
Crossref
C. Peña, C. Gudiol, F. Tubau, M. Saballs, M. Pujol, M.A. Dominguez, L. Calatayud, J. Ariza & F. Gudiol. (2006) Risk-factors for acquisition of extended-spectrum β-lactamase-producing Escherichia coli among hospitalised patients. Clinical Microbiology and Infection 12:3, pages 279-284.
Crossref
Crossref
Sujata M. Bhavnani, Paul G. Ambrose, William A. Craig, Michael N. Dudley & Ronald N. Jones. (2006) Outcomes evaluation of patients with ESBL- and non–ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program. Diagnostic Microbiology and Infectious Disease 54:3, pages 231-236.
Crossref
Crossref
Faustine Ndugulile, Roland Jureen, Stig Harthug, Willy Urassa & Nina Langeland. (2005) Extended Spectrum β-Lactamases among Gram-negative bacteria of nosocomial origin from an Intensive Care Unit of a tertiary health facility in Tanzania. BMC Infectious Diseases 5:1.
Crossref
Crossref
David L. Paterson & Robert A. Bonomo. (2005) Extended-Spectrum β-Lactamases: a Clinical Update. Clinical Microbiology Reviews 18:4, pages 657-686.
Crossref
Crossref
P. L. Ho, Alex Y. M. Ho, K. H. Chow, River C. W. Wong, R. S. Duan, W. L. Ho, Gannon C. Mak, Kenneth W. Tsang, W. C. Yam & K. Y. Yuen. (2005) Occurrence and molecular analysis of extended-spectrum β-lactamase-producing Proteus mirabilis in Hong Kong, 1999–2002. Journal of Antimicrobial Chemotherapy 55:6, pages 840-845.
Crossref
Crossref
George A. Jacoby & Luisa Silvia Munoz-Price. (2005) The New β-Lactamases. New England Journal of Medicine 352:4, pages 380-391.
Crossref
Crossref
Enno Stürenburg & Dietrich Mack. (2003) Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. Journal of Infection 47:4, pages 273-295.
Crossref
Crossref
Kalpana Gupta. (2003) Emerging antibiotic resistance in urinary tract pathogens. Infectious Disease Clinics of North America 17:2, pages 243-259.
Crossref
Crossref